F-Prime Capital Partners - Massinvestor Venture Capital and Private Equity Database

VC F-Prime Capital Partners

http://fprimecapital.com/

Office Locations:

1 Main Street, 13th Floor
Cambridge, MA 02142
Phone: 617-231-2400

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.

Stages:

Early
Growth
Seed

Industries:

Financial Services

Information Technology

Life Sciences & Healthcare

Description:

F-Prime is made up of a portion of Devonshire Investors and the former Fidelity Investments, which was founded in 1946 as a single mutual fund and grew into one of the largest asset management firms in the world, with over $2 trillion in assets under management. The firm also includes sister fund Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. In healthcare, F-Prime focuses on Biopharmaceuticals, MedTech, and Healthcare IT/Services in a stage-agnostic fashion. In technology, the firm focuses on Enterprise IT and FinTech, with a strong enterprise focus in both.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database

▶ 5,000 Firms

▶ 18,000 Partner Emails

▶ 30,000 Portfolio
companies

Investment Team:

Name		Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
Alex Pasteur	Ph.D.	Partner
Anastasiya Sybirna	Ph.D.	Associate
Carl Byers		Executive Partner
David Jegen		Managing Partner
Jessica Alston	Ph.D.	Partner

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
03/19/2024	Engrail Therapeutics	CA	$157,000,000	Series B
03/04/2024	Nocion Therapeutics	MA	$62,000,000	Series B
01/11/2024	Dispatch Data	FL	$8,000,000	Seed
12/07/2023	ARTBIO	MA	$90,000,000	Series A
11/08/2023	Eleos Health	MA	$40,000,000	Series B
09/29/2023	Avalyn Pharma	WA	$175,000,000	Series C
06/13/2023	Albert Invent	CA	$7,500,000	Seed
05/09/2023	1upHealth	MA	$40,000,000	Series C